Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure: A Retrospective Cohort Study Stratified by Right Ventricular Dysfunction Severity

NCT06582459 is registered in ClinicalTrials.gov with The First People's Hospital of Neijiang as lead sponsor.

NCT NCT06582459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06582459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure: A Retrospective Cohort Study Stratified by Right Ventricular Dysfunction Severity
Lead sponsor
The First People's Hospital of Neijiang
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2023
Completion date
January 1, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, high-flow nasal cannula, noninvasive ventilation, pulmonary arterial hypertension